Analyzing the extent to which these RNA-based mechanisms alter or restore physiological A1AT expression in the lung would inform future strategies to treat A1AT deficiency. The gene discussed is SERPINA1; the disease is hyperinsulinemic hypoglycemia, familial, 4.